|
End-of-day quote
TEL AVIV STOCK EXCHANGE
16/10/2026
|
5-day change | 1st Jan Change | ||
| 1,823.00 ILa | +0.16% |
|
+6.48% | - |
| 07-14 | Rafa Laboratories Ltd. has completed an IPO in the amount of ILS 549.8718 million. | CI |
| 07-08 | Rafa Laboratories Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
TEL AVIV STOCK EXCHANGEILa
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| RAFA | End-of-day quote | |
TEL AVIV STOCK EXCHANGE
| RAFA | Delayed |
| 1 day | +0.16% | ||
| 1 week | +6.48% | ||
| Current month | +0.66% | ||
| 1 month | +11.91% | ||
| 3 months | +16.63% |
| 1 week | 1,685 |  | 1,854 |
| 1 month | 1,577 | | 1,999 |
| Current year | 1,401 | | 1,999 |
| 1 year | 1,401 | | 1,999 |
| 3 years | 1,401 | | 1,999 |
| 5 years | 1,401 | | 1,999 |
| 10 years | 1,401 | | 1,999 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ido Leshem
CEO | Chief Executive Officer | 50 | 31/12/2023 |
Gabi Hazan
COO | Chief Operating Officer | 58 | 31/12/2006 |
Yael Paula Tomer
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gillon Beck
BRD | Director/Board Member | 64 | 30/12/2020 |
Abraham Dadon
BRD | Director/Board Member | 70 | 26/05/2026 |
Amir Levin
BRD | Director/Board Member | 60 | 25/06/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.16% | +6.48% | - | - | 576M | |
| +0.43% | +6.59% | +56.57% | +106.64% | 1,120B | |
| +0.90% | -2.25% | +32.26% | +63.73% | 616B | |
| +0.71% | +3.24% | +24.33% | +91.33% | 504B | |
| -0.13% | +5.98% | +33.66% | +50.18% | 367B | |
| +0.52% | +0.24% | +72.13% | +40.11% | 360B | |
| -0.95% | +4.70% | +19.65% | +42.71% | 288B | |
| -1.98% | +3.73% | -0.89% | +10.43% | 258B | |
| -0.35% | +4.25% | +44.74% | +52.06% | 234B | |
| -0.75% | +3.32% | +27.18% | +94.07% | 194B | |
| Average | -0.14% | +3.68% | +34.40% | +61.25% | 394.15B | |
| Weighted average by Cap. | +0.13% | +3.83% | +39.34% | +71.82% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 420M 0 135M 120M 112M 102M 192M 12.85B 195M 1.34B 526M 6.71B 508M 498M 21.38B | 418M 0 135M 120M 111M 101M 191M 12.8B 194M 1.34B 524M 6.68B 506M 496M 21.3B |
| Net income | 99.43M 0 32.06M 28.5M 26.41M 24.03M 45.35M 3.04B 46.07M 317M 124M 1.59B 120M 118M 5.06B | 100M 0 32.35M 28.76M 26.65M 24.25M 45.76M 3.07B 46.49M 320M 126M 1.6B 121M 119M 5.11B |
| Net Debt | - | - |
Employees
257
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | ILA 1,823.00 | +0.16% | 6,476 |
| 15/10/26 | ILA 1,820.00 | +1.39% | 7,387 |
| 14/10/26 | ILA 1,795.00 | +0.96% | 10,943 |
| 13/10/26 | ILA 1,778.00 | +1.72% | 5,532 |
| 12/10/26 | ILA 1,748.00 | +2.10% | 10,685 |
- Stock Market
- Stocks
- RAFA Stock
Select your edition
All financial news and data tailored to specific country editions
